Horizon 2020 European Joint Program on Rare Diseases grant received by Sven van IJzendoorn
 |
Almost 1 million Euro for research on an ultra-rare disease
The Horizon 2020 European Joint Program on Rare Diseases awarded EUR 932.000 to an international consortium led by UMCG professor Sven van IJzendoorn (department of Biomedical Sciences of Cells & Systems) to develop an antioxidant treatment as a novel therapeutic option for microvillus inclusion disease (MVID). MVID is a rare disease with no cure, characterized by unstoppable diarrhea and the inability to absorb dietary nutrients. Professor van IJzendoorn is a leading expert on this disease and initiator of the world-wide MVID registry. Recent studies in his laboratory have shed new light on the cellular mechanisms that underlie this disease. This provided leads for a novel therapeutic option which, with the awarded grant, will be further developed in a European setting towards the clinic. Links: EJP RD-website: https://www.ejprarediseases.org/index.php/funded-projects-2020 A short movie for laymen about MVID (in Dutch): https://www.youtube.com/watch?v=5BnFxfG-Dfk The world-wide MVID registry: www.mvid-central.org The researchteam of van IJzendoorn: https://bscs.umcg.nl/nl/groups/groep-van-ijzendoorn/ |
